| benign inoculation reticulosis | <disease> A self-limiting bacterial infection of the regional lymph nodes (lymphadenitis) caused by afipia felis, a gram-negative bacterium recently identified as bartonella henselae. It usually arises one or more weeks following a feline scratch, with raised inflammatory nodules at the site of the scratch being the primary symptom. It results in tender and enlarged lymph glands above the site of injury. A chronic benign adenopathy, especially in children and young adults, commonly associated with a recent cat scratch or bite and caused by bacteria including Bartonella henselae and Alipia felis; the lymphadenopathy usually resolves spontaneously within a period of several months, but complications involving central nervous system, liver, spleen, lung, and skin have been seen. Synonym: benign inoculation lymphoreticulosis, benign inoculation reticulosis, cat-scratch fever, regional granulomatous lymphadenitis. (05 Mar 2000) |
|---|---|
| pagetoid reticulosis | A benign localised form of lymphoma with solitary or closely grouped cutaneous tumours consisting of predominantly epidermal infiltration of mononuclear cells resembling those found in mycosis fungoides. Synonym: pagetoid reticulosis. (05 Mar 2000) |
| malignant midline reticulosis | An obsolete term for polymorphic reticulosis (05 Mar 2000) |
| reticulosis | 1. An increase in histiocytes, monocytes, or other reticuloendothelial elements. 2. Obsolete term for lymphoma. Origin: reticulo-+ G. -osis, condition (05 Mar 2000) |
| midline malignant reticulosis granuloma | Destruction of the nasal septum, hard palate, lateral nasal walls, paranasal sinuses, skin of the face, orbit and nasopharynx by an inflammatory infiltrate with atypical lymphocytic and histiocytic cells; presumably a form of lymphoma in most cases. An obsolete term for polymorphic reticulosis. Synonym: granuloma gangrenescens, malignant granuloma, midline malignant reticulosis granuloma. (05 Mar 2000) |
| polymorphic reticulosis | A necrotizing lymphoproliferative lesion with a predilection for the upper respiratory tract. Previously called lethal midline granuloma or malignant midline reticulosis. Treatment is irradiation. (05 Mar 2000) |
| leukaemic reticulosis | Cancer of the blood due to proliferation of cells of the monocyte series. Origin: Gr. Haima = blood (13 Nov 1997) |
| lipomelanic reticulosis | Enlargement of lymph nodes, with proliferation of pale-staining interdigitating reticulum cells and macrophages containing fat and melanin; secondary to various forms of dermatitis. Synonym: dermatopathic lymphadenitis, lipomelanic reticulosis. (05 Mar 2000) |
| acute inflammatory polyneuropathy | <neurology, syndrome> Acute infective polyneuritis that results in a form of peripheral neuropathy with temporary loss of movement and sensation due to inflammation of multiple nerves and loss of myelin. The exact cause is unknown but has been associated with an abnormal immune response to viral infection, particularly cytomegalovirus infection, in which there is cell-mediated immunity to a component of myelin. The disease may be autoimmune in origin and complete recovery can take up to six months. Synonym: Guillain-Barre syndrome (12 Jul 2000) |
| anti-inflammatory | Counteracting or suppressing inflammation. (18 Nov 1997) |
| anti-inflammatory agent | Agents that counteract or suppress the inflammatory process. An antirheumatic agent or inflammation mediator, both endogenous and exogenous substances used to counteract the inflammatory process or alleviate or prevent rheumatic diseases, and the compounds that mediate the inflammation process. (12 Dec 1998) |
| anti-inflammatory agent, non-steroidal | Anti-inflammatory agents that are not steroids. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They are used primarily in the treatment of chronic arthritic conditions and certain soft tissue disorders associated with pain and inflammation. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. Certain nsaids also may inhibit lipoxygenase enzymes or phospholipase c or may modulate T-cell function. (ama drug evaluations annual, 1994, p 1814-5) (12 Dec 1998) |
| anti-inflammatory agent, steroidal | Steroidal agents capable of suppressing or counteracting the inflammatory process by acting on body mechanisms, without directly antagonizing the causative agents. (12 Dec 1998) |
| anti-inflammatory agent, topical | Anti-inflammatory agent that are applied to the skin and whose pharmacological effect only occurs at the area of application. (12 Dec 1998) |
| macrophage inflammatory protein | <cytokine> A chemokine that is chemotactic for neutrophils and monocytes, stimulates macrophages, and may play a role in regulating haematopoiesis. Its two variants, mip-1alpha and mip-1beta, are 60% homologous to each other. They are heparin-binding proteins that exhibit a number of inflammatory and immunoregulatory activities. Originally identified as secretory products of macrophages, these chemokines are produced by a variety of cell types including neutrophils, fibroblasts, and epithelial cells. They most likely also play a significant role in respiratory tract defenses. (20 Sep 2002) |